Navigation Links
IVMD Inc. Announces Fundamental Balance Sheet Restructuring.
Date:4/24/2008

(OTCBB: IVME; Frankfurt: I7VF)

INVERNESS, Scotland, April 24 /PRNewswire-FirstCall/ - In Veritas announces that it has secured a fundamental balance sheet restructuring leaving it free of all loan note indebtedness, and that it has secured a further equity capital line to enable it to move forward. The Company has been frustrated under the pressure of excessive debt since late 2005.

Medical Diagnostic Innovations Ltd, a UK investment company formed by Mr. Graham Cooper, the Company's Chief Executive Officer, and others to facilitate the restructuring, has entered into agreements to purchase $3,316,324 of the Company's debt (convertible loan notes and other indebtedness to the Company's various loan note holders) and has agreed to convert that debt into shares of the Company's common stock. The balance of the Company's indebtedness under convertible loan notes has been converted into Common stock by those Loan Note holders. All conversions took place at 5 cents per share.

Mr. Cooper has agreed to personally purchase $300,000 of shares in the Company's common stock by way of a private placement at a price of 5 cents per share.

In addition key employees, directors and contractors of the Company have been granted warrants to purchase shares in the Company's common stock in a move designed to secure the commitment and ongoing mutuality of interest between the Company and key people who will be associated with its future success.

This restructuring eliminates liabilities of approximately $5,487,279 from its balance sheet, representing some 68% of the Company's net liabilities reported in its consolidated financial statements at January 31, 2008.

Mr. Cooper, commenting on these important events said:

"I am delighted that after many months of deadlock the Company is now free of its overbearing burden of debt and able to explore its true potential. We now plan to transform the Company into a profitable innovator in the field of point of care medical diagnostics. At last we can concentrate on the business and the substantial commercial opportunities that we have created, rather than internalise around financial complexities".

Martin Thorp, the Chief Financial Officer added:

"Financing the Company by loan notes was never appropriate and was forced upon previous management by extraneous factors. Extricating In Veritas from the complex debt was not easy, but we have now done it and the commercial opportunity ahead is very exciting. I want to mention those of our trade creditors in Scotland, England and the US who have been enormously understanding of In Veritas' problems and greatly supportive of us during the lengthy period over which we have been locked in negotiation with our US loan note holders".

About In Veritas Medical Diagnostics, Inc.

IVMD uses its proven, patented core technology to design, develop and test medical devices for near patient testing and monitoring. Our products serve large global markets in the monitoring of chronic conditions affecting large numbers of the population.

Forward-Looking Statements

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995 -- With the exception of historical information, the matters discussed in this press release are forward-looking statements that involve a number of risks and uncertainties. Our actual future results of could differ significantly from those statements. Factors that could cause actual results to differ materially include risks and uncertainties such as the inability to finance the company's operations or expansion, inability to hire and retain qualified personnel, changes in the general economic climate, including rising interest rates and unanticipated events such as terrorist activities. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential" or "continue," the negative of such terms, or other comparable terminology. These statements are only predictions. Although we believe that the expectations reflected in the forward-looking statements are reasonable, such statements should not be regarded as a representation by the Company, or any other person, that such forward-looking statements will be achieved. We undertake no duty to update any of the forward-looking statements, whether as a result of new information, future events or otherwise. In light of the foregoing, readers are cautioned not to place undue reliance on such forward-looking statements. For further risk factors see the risk factors associated with our Company, review our SEC filings.

CONTACT: Martin Thorp, +44 (0) 207 499 1730


'/>"/>
SOURCE In Veritas Medical Diagnostics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, ... Rock Hotel San Diego honoring the 2016 MPN Heroes—eight individuals who have made a ... going above and beyond the standard of care, demonstrating leadership within the MPN community ...
(Date:12/2/2016)... ... 2016 , ... FlexiSpot, a trusted name in sit-stand solutions ... for all of the company’s desktop riser products. A simple application form and ... FlexiSpot’s unique desktop risers use an advanced dual gas spring hovering system to ...
(Date:12/2/2016)... ... 02, 2016 , ... With the number of pain management programs available for ... find the one that works for them. When an inventor from Suisun City, Calif., ... and decided to share it with others. , He developed a prototype for PRO ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... edition of "Cardiovascular Health" in USA Today, which covers the innovative treatments, therapeutic ... health while maintaining fulfilling lives. “We are prolonging life 6 years in the ...
(Date:12/2/2016)... ... December 02, 2016 , ... Sourced from the Isbre Springs beneath the 5,000 ... unmatched natural purity of just 6 ppm TDS (Total Dissolved Solids) in addition to ... been available in several ShopRite and FoodTown stores in NJ and received rave comments ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... -- Maxor National Pharmacy Services, LLC ("Maxor"), today announced that it ... combination of Texas -based Maxor Specialty / ... together both company,s clinical expertise and high-touch patient service models ... pharmacy. About Maxor ... , , ...
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
Breaking Medicine Technology: